Q4 2024 Results Conference Call February 4, 2025 8:30 AM ETCompany ParticipantsMiri Segal - CEO, MS-IRMoshe Mizrahy - ...
ONCE upon a time, “work” meant a boring 9 to 5. Today, in my world, it means Botox, filler, polynucleotides, Profhilo, ...
The Post spoke to Dr. Patrick J. Byrne, president of AAFPRS, to discuss the booming “man-esthetics” trend, from the most popular procedures to the issues driving men to the operating table.
With the $1.1 billion acquisition, Zimmer Biomet expects its sports medicine, extremities and trauma segment will outpace ...
News Medical on MSN4d
USC to lead $10.8 million study on hip fracture surgery optionsThe University of Southern California has been approved for $10.8 million in research funding by the Patient-Centered ...
Reported recurrence rates of lentigo maligna treated with Mohs micrographic surgery have ranged from 0.5 to 30.0% in the ...
InMode Ltd (NASDAQ:INMD) reported its financial results for the fourth quarter of 2024, revealing a shortfall in both earnings and revenue compared to market expectations. The company's earnings per ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback